Cantor Fitzgerald Increases Price Target for Sandisk Corp. (SNDK)
Corroborated by 2 sources from 2 publishers
TL;DR
Sandisk Corp Cantor Fitzgerald reiterates Gilead Sciences stock rating on HIV drug approval.
Sources
1
Yahoo Finance News
https://finance.yahoo.com/markets/stocks/articles/cantor-fitzgerald-increases-price-target-110256637.html
2
Investing.com News
https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-reiterates-gilead-sciences-stock-rating-on-hiv-drug-approval-93CH-4744587
3
Investing.com News
https://www.investing.com/news/analyst-ratings/cantor-cuts-domo-stock-price-target-on-debt-covenant-breach-93CH-4744588
4
Investing.com News
https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-reiterates-coreweave-stock-overweight-on-backlog-93CH-4744589
5
Investing.com News
https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-reiterates-emcor-group-stock-rating-on-execution-focus-93CH-4744590